相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Impact of Obesity on the Incidence of Type 2 Diabetes Among Women With Polycystic Ovary Syndrome
Nadira S. Kakoly et al.
DIABETES CARE (2019)
Characterization of metabolic changes in the phenotypes of women with polycystic ovary syndrome in a large Mediterranean population from Sicily
Enrico Carmina et al.
CLINICAL ENDOCRINOLOGY (2019)
Androgen profile in young females with insulin resistance; the importance of 17-Hydroxyprogesterone Androgens in young insulin resistant females
Mehdi Basaki et al.
GYNECOLOGICAL ENDOCRINOLOGY (2019)
Age at Onset of Metabolic Syndrome Among Women With and Without Polycystic Ovary Syndrome-Like Status
Qing Peng et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
Metabolic syndrome in polycystic ovary syndrome: a systematic review, meta-analysis and meta-regression
S. S. Lim et al.
OBESITY REVIEWS (2019)
Effects of combined oral contraceptives on the clinical and biochemical parameters of hyperandrogenism in patients with polycystic ovary syndrome: a systematic review and meta-analysis
Mina Amiri et al.
EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE (2018)
Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome
Helena J. Teede et al.
FERTILITY AND STERILITY (2018)
Lean polycystic ovary syndrome (PCOS): an evidence-based practical approach
Sehar Toosy et al.
JOURNAL OF DIABETES AND METABOLIC DISORDERS (2018)
Overweight and obese but not normal weight women with PCOS are at increased risk of Type 2 diabetes mellitus-a prospective, population-based cohort study
M. -M. E. Ollila et al.
HUMAN REPRODUCTION (2017)
The prevalence of Type 2 diabetes is not increased in normal-weight women with PCOS
Rasa Pelanis et al.
HUMAN REPRODUCTION (2017)
Development and Risk Factors of Type 2 Diabetes in a Nationwide Population of Women With Polycystic Ovary Syndrome
Katrine Hass Rubin et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2017)
The First Decade with the Swedish Prescribed Drug Register - A Systematic Review of the Output in the Scientific Literature
Susanna M. Wallerstedt et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2016)
Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus
Alexandra Kautzky-Willer et al.
ENDOCRINE REVIEWS (2016)
Registers of the Swedish total population and their use in medical research
Jonas F. Ludvigsson et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2016)
Criteria, prevalence, and phenotypes of polycystic ovary syndrome
Daria Lizneva et al.
FERTILITY AND STERILITY (2016)
The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis
Gurkan Bozdag et al.
HUMAN REPRODUCTION (2016)
The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance
Adam H. Balen et al.
HUMAN REPRODUCTION UPDATE (2016)
Long-term effects of oral contraceptives on the prevalence of diabetes in post-menopausal women: 2007-2012 KNHANES
Sung-Woo Kim et al.
ENDOCRINE (2016)
Revised criteria for PCOS in WHO Group II anovulatory infertility - a revival of hypothalamic amenorrhoea?
Mette Petri Lauritsen et al.
CLINICAL ENDOCRINOLOGY (2015)
Cardiovascular and metabolic profiles amongst different polycystic ovary syndrome phenotypes: who is really at risk?
Nadine M. P. Daan et al.
FERTILITY AND STERILITY (2014)
Polycystic Ovary Syndrome Is a Risk Factor for Type 2 Diabetes: Results from a Long-Term Prospective Study
Alessandra Gambineri et al.
DIABETES (2012)
Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group
Bart C. J. M. Fauser et al.
FERTILITY AND STERILITY (2012)
External review and validation of the Swedish national inpatient register
Jonas F. Ludvigsson et al.
BMC PUBLIC HEALTH (2011)
Diabetes risk score in the diagnostic categories of polycystic ovary syndrome
Lisa J. Moran et al.
FERTILITY AND STERILITY (2011)
Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan
H. Teede et al.
BMC MEDICINE (2010)
Effect of oral contraceptive containing ethinyl estradiol combined with drospirenone vs. desogestrel on clinical and biochemical parameters in patients with polycystic ovary syndrome
Alka Kriplani et al.
CONTRACEPTION (2010)
Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis
Lisa J. Moran et al.
HUMAN REPRODUCTION UPDATE (2010)
The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research
Jonas F. Ludvigsson et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2009)
Criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: An Androgen Excess Society guideline
Ricardo Azziz et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
PCOS according to the Rotterdam consensus criteria: change in prevalence among WHO-II anovulation and association with metabolic factors
F. J. Broekmans et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2006)
Oral contraceptive use and risk of diabetes among Chinese women
AD Rosenthal et al.
CONTRACEPTION (2004)
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
J Chang et al.
FERTILITY AND STERILITY (2004)
分享论文
